Skip to main content

Peer Review reports

From: Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy

Original Submission
5 Feb 2009 Submitted Original manuscript
5 Feb 2009 Author responded Author comments - David Hedley
Resubmission - Version 2
5 Feb 2009 Submitted Manuscript version 2
31 Mar 2009 Author responded Author comments - David Hedley
2 Mar 2009 Reviewed Reviewer Report - Richard Bold
4 Mar 2009 Reviewed Reviewer Report - Heiner Schäfer
5 Mar 2009 Reviewed Reviewer Report - Michele Yip-Schneider
Resubmission - Version 3
31 Mar 2009 Submitted Manuscript version 3
Publishing
30 Apr 2009 Editorially accepted
30 Apr 2009 Article published 10.1186/1471-2407-9-132

You can find further information about peer review here.

Back to article page
\